Sunshine Biopharma Inc. Stock-Based Compensation
Sunshine Biopharma Inc. (SBFM) reported Stock-Based Compensation of $271.93 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-03-30
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for the quarter ending 2016-12-31 was $79.90K.
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for the quarter ending 2016-09-30 was $156.50K.
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for the quarter ending 2016-06-30 was $263.00K, a 125.75% increase year-over-year.
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for the quarter ending 2016-03-31 was $0.00.
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $271.93K, a 1.92% decline from fiscal 2019.
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for fiscal 2019 was $277.25K, a 63.29% decline from fiscal 2018.
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for fiscal 2018 was $755.22K, a 45.16% increase from fiscal 2017.
- Sunshine Biopharma Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $520.27K, a 4.18% increase from fiscal 2016.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 19 month | Share-based Payment Arrangement, Noncash Expense 22 month | Share-based Payment Arrangement, Noncash Expense 25 month | Share-based Payment Arrangement, Noncash Expense 28 month | Share-based Payment Arrangement, Noncash Expense 31 month | Share-based Payment Arrangement, Noncash Expense 34 month | Share-based Payment Arrangement, Noncash Expense 37 month | Share-based Payment Arrangement, Noncash Expense 40 month | Share-based Payment Arrangement, Noncash Expense 43 month | Share-based Payment Arrangement, Noncash Expense 46 month | Share-based Payment Arrangement, Noncash Expense 49 month | Share-based Payment Arrangement, Noncash Expense 55 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $271.93K 10-K · filed 2021-03-30 | |||||||||||||||||
| 2019-12-31 | $277.25K 10-K · filed 2021-03-30 | |||||||||||||||||
| 2018-12-31 | $755.22K 10-K · filed 2020-05-01 | |||||||||||||||||
| 2017-12-31 | $520.27K 10-K · filed 2019-04-12 | |||||||||||||||||
| 2016-12-31 | $79.90K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $236.40K derived: sum of 2 quarters · filed 2018-04-02 | $499.40K derived: sum of 3 quarters · filed 2018-04-02 | $499.40K 10-K · filed 2018-04-02 | $702.30K 10-K · filed 2017-04-17 | |||||||||||||
| 2016-09-30 | $156.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $419.50K derived: sum of 2 quarters · filed 2016-11-14 | $419.50K 10-Q · filed 2016-11-14 | $419.50K derived: sum of 4 quarters · filed 2017-04-17 | ||||||||||||||
| 2016-06-30 | $263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | $263.00K 10-Q · filed 2016-08-16 | $263.00K derived: sum of 3 quarters · filed 2017-04-17 | $263.00K derived: sum of 4 quarters · filed 2017-04-17 | ||||||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2017-04-17 | $0.00 derived: sum of 3 quarters · filed 2017-04-17 | $116.50K derived: sum of 4 quarters · filed 2017-04-17 | ||||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $0.00 derived: sum of 2 quarters · filed 2017-04-17 | $116.50K derived: sum of 3 quarters · filed 2017-04-17 | $116.50K 10-K · filed 2017-04-17 | ||||||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $116.50K derived: sum of 2 quarters · filed 2016-11-14 | $116.50K 10-Q · filed 2016-11-14 | $288.52K derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||||||
| 2015-06-30 | $116.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | $116.50K 10-Q · filed 2016-08-16 | $288.52K derived: sum of 3 quarters · filed 2016-08-16 | $513.71K derived: sum of 4 quarters · filed 2016-08-16 | ||||||||||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | $172.02K derived: sum of 2 quarters · filed 2016-05-09 | $397.21K derived: sum of 3 quarters · filed 2016-05-09 | $990.61K derived: sum of 4 quarters · filed 2016-05-09 | ||||||||||||||
| 2014-12-31 | $172.02K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $397.21K derived: sum of 2 quarters · filed 2016-03-25 | $990.61K derived: sum of 3 quarters · filed 2016-03-25 | $1.26M 10-K · filed 2016-03-25 | ||||||||||||||
| 2014-09-30 | $225.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $818.59K derived: sum of 2 quarters · filed 2015-11-04 | $1.09M 10-Q · filed 2015-11-04 | $1.62M derived: sum of 4 quarters · filed 2015-11-04 | ||||||||||||||
| 2014-06-30 | $593.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $860.80K 10-Q · filed 2015-08-06 | $1.39M derived: sum of 3 quarters · filed 2015-08-06 | $1.47M derived: sum of 4 quarters · filed 2015-08-06 | ||||||||||||||
| 2014-03-31 | $267.40K 10-Q · filed 2015-05-07 | $797.40K derived: sum of 2 quarters · filed 2015-05-07 | $877.40K derived: sum of 3 quarters · filed 2015-05-07 | $937.40K derived: sum of 4 quarters · filed 2015-05-07 | $2.94M 10-Q · filed 2014-05-09 | |||||||||||||
| 2013-12-31 | $530.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $610.00K derived: sum of 2 quarters · filed 2015-03-11 | $670.00K derived: sum of 3 quarters · filed 2015-03-11 | $1.25M 10-K · filed 2015-03-11 | $2.67M 10-K · filed 2014-03-19 | |||||||||||||
| 2013-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $140.00K derived: sum of 2 quarters · filed 2014-11-12 | $716.31K 10-Q · filed 2014-11-12 | $722.31K derived: sum of 4 quarters · filed 2014-11-12 | $2.14M 10-Q · filed 2013-11-04 | |||||||||||||
| 2013-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $636.31K 10-Q · filed 2014-08-12 | $642.31K derived: sum of 3 quarters · filed 2014-08-12 | $909.18K derived: sum of 4 quarters · filed 2014-08-12 | $2.06M 10-Q · filed 2013-08-06 | |||||||||||||
| 2013-03-31 | $576.31K 10-Q · filed 2014-05-09 | $582.31K derived: sum of 2 quarters · filed 2014-05-09 | $849.18K derived: sum of 3 quarters · filed 2014-05-09 | $849.18K derived: sum of 4 quarters · filed 2014-05-09 | $2.00M 10-Q · filed 2013-05-09 | |||||||||||||
| 2012-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $272.88K derived: sum of 2 quarters · filed 2014-03-19 | $272.88K derived: sum of 3 quarters · filed 2014-03-19 | $272.88K 10-K · filed 2014-03-19 | $1.43M 10-K · filed 2013-03-15 | |||||||||||||
| 2012-09-30 | $266.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $266.88K derived: sum of 2 quarters · filed 2013-11-04 | $266.88K 10-Q · filed 2013-11-04 | $522.26K derived: sum of 4 quarters · filed 2013-11-04 | $1.42M 10-Q · filed 2012-11-08 | |||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | $69.00K 10-Q · filed 2012-08-08 | $255.38K derived: sum of 3 quarters · filed 2013-08-06 | $255.38K derived: sum of 4 quarters · filed 2013-08-06 | $1.22M 10-Q · filed 2012-08-08 | ||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 | $255.38K derived: sum of 2 quarters · filed 2013-05-09 | $255.38K derived: sum of 3 quarters · filed 2013-05-09 | $267.38K derived: sum of 4 quarters · filed 2013-05-09 | $1.15M 10-Q · filed 2012-05-08 | |||||||||||||
| 2011-12-31 | $255.38K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $255.38K derived: sum of 2 quarters · filed 2013-03-15 | $267.38K derived: sum of 3 quarters · filed 2013-03-15 | $267.38K 10-K · filed 2013-03-15 | $1.15M 10-K · filed 2012-03-19 | |||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $12.00K derived: sum of 2 quarters · filed 2012-11-08 | $12.00K 10-Q · filed 2012-11-08 | -$402.77K derived: sum of 4 quarters · filed 2012-11-08 | $899.13K 10-Q · filed 2011-11-08 | |||||||||||||
| 2011-06-30 | $12.00K 10-Q · filed 2011-08-09 | $12.00K 10-Q · filed 2012-08-08 | -$402.77K derived: sum of 3 quarters · filed 2012-05-08 | $899.13K 10-Q · filed 2011-08-09 | ||||||||||||||
| 2011-03-31 | $12.00K 10-Q · filed 2012-05-08 | -$414.77K derived: sum of 2 quarters · filed 2012-05-08 | $899.13K 10-Q · filed 2011-05-12 | |||||||||||||||
| 2010-12-31 | -$426.77K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-19 | $237.20K 10-K · filed 2012-03-19 | ||||||||||||||||
| 2010-09-30 | $663.97K 10-Q · filed 2011-11-08 | |||||||||||||||||
| 2010-06-30 | $1.57M 10-Q · filed 2011-08-09 | $1.57M derived: sum of 2 quarters · filed 2011-08-09 | ||||||||||||||||
| 2010-03-31 | $0.00 10-Q · filed 2011-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |